Global ?-Valerolactone Market Insights, Forecast to 2029
This report presents an overview of global market for ?-Valerolactone, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of ?-Valerolactone, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for ?-Valerolactone, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the ?-Valerolactone sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global ?-Valerolactone market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for ?-Valerolactone sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including BASF, Ube Industries, MYJ Chemical, Ningbo INNO Pharmchem, Skylead Pharmaceuticals & Chemicals, Penta Manufacturing and Zhejiang Boadge Chemical, etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: ?-Valerolactone production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of ?-Valerolactone in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of ?-Valerolactone manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 9: China by type and by application sales and revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, ?-Valerolactone sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
This report researches the key producers of ?-Valerolactone, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for ?-Valerolactone, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the ?-Valerolactone sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global ?-Valerolactone market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for ?-Valerolactone sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including BASF, Ube Industries, MYJ Chemical, Ningbo INNO Pharmchem, Skylead Pharmaceuticals & Chemicals, Penta Manufacturing and Zhejiang Boadge Chemical, etc.
By Company
- BASF
- Ube Industries
- MYJ Chemical
- Ningbo INNO Pharmchem
- Skylead Pharmaceuticals & Chemicals
- Penta Manufacturing
- Zhejiang Boadge Chemical
- Assay: 98%
- Assay: 99%
- Coatings, Adhesives, Resin Additives
- Pharmaceutical and Agrochemical Intermediates
- North America
- Europe
- China
- Japan
- US & Canada
- U.S.
- Canada
- China
- Asia (excluding China)
- Japan
- South Korea
- China Taiwan
- Southeast Asia
- India
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Middle East, Africa, Latin America
- Brazil
- Mexico
- Turkey
- Israel
- GCC Countries
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: ?-Valerolactone production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of ?-Valerolactone in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of ?-Valerolactone manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 9: China by type and by application sales and revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, ?-Valerolactone sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
1 STUDY COVERAGE
1.1 ?-Valerolactone Product Introduction
1.2 Market by Type
1.2.1 Global ?-Valerolactone Market Size by Type, 2018 VS 2022 VS 2029
1.2.2 Assay: 98%
1.2.3 Assay: 99%
1.3 Market by Application
1.3.1 Global ?-Valerolactone Market Size by Application, 2018 VS 2022 VS 2029
1.3.2 Coatings, Adhesives, Resin Additives
1.3.3 Pharmaceutical and Agrochemical Intermediates
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL ?-VALEROLACTONE PRODUCTION
2.1 Global ?-Valerolactone Production Capacity (2018-2029)
2.2 Global ?-Valerolactone Production by Region: 2018 VS 2022 VS 2029
2.3 Global ?-Valerolactone Production by Region
2.3.1 Global ?-Valerolactone Historic Production by Region (2018-2023)
2.3.2 Global ?-Valerolactone Forecasted Production by Region (2024-2029)
2.3.3 Global ?-Valerolactone Production Market Share by Region (2018-2029)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 EXECUTIVE SUMMARY
3.1 Global ?-Valerolactone Revenue Estimates and Forecasts 2018-2029
3.2 Global ?-Valerolactone Revenue by Region
3.2.1 Global ?-Valerolactone Revenue by Region: 2018 VS 2022 VS 2029
3.2.2 Global ?-Valerolactone Revenue by Region (2018-2023)
3.2.3 Global ?-Valerolactone Revenue by Region (2024-2029)
3.2.4 Global ?-Valerolactone Revenue Market Share by Region (2018-2029)
3.3 Global ?-Valerolactone Sales Estimates and Forecasts 2018-2029
3.4 Global ?-Valerolactone Sales by Region
3.4.1 Global ?-Valerolactone Sales by Region: 2018 VS 2022 VS 2029
3.4.2 Global ?-Valerolactone Sales by Region (2018-2023)
3.4.3 Global ?-Valerolactone Sales by Region (2024-2029)
3.4.4 Global ?-Valerolactone Sales Market Share by Region (2018-2029)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 COMPETITION BY MANUFACTURES
4.1 Global ?-Valerolactone Sales by Manufacturers
4.1.1 Global ?-Valerolactone Sales by Manufacturers (2018-2023)
4.1.2 Global ?-Valerolactone Sales Market Share by Manufacturers (2018-2023)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of ?-Valerolactone in 2022
4.2 Global ?-Valerolactone Revenue by Manufacturers
4.2.1 Global ?-Valerolactone Revenue by Manufacturers (2018-2023)
4.2.2 Global ?-Valerolactone Revenue Market Share by Manufacturers (2018-2023)
4.2.3 Global Top 10 and Top 5 Companies by ?-Valerolactone Revenue in 2022
4.3 Global ?-Valerolactone Sales Price by Manufacturers
4.4 Global Key Players of ?-Valerolactone, Industry Ranking, 2021 VS 2022 VS 2023
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global ?-Valerolactone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of ?-Valerolactone, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of ?-Valerolactone, Product Offered and Application
4.8 Global Key Manufacturers of ?-Valerolactone, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 MARKET SIZE BY TYPE
5.1 Global ?-Valerolactone Sales by Type
5.1.1 Global ?-Valerolactone Historical Sales by Type (2018-2023)
5.1.2 Global ?-Valerolactone Forecasted Sales by Type (2024-2029)
5.1.3 Global ?-Valerolactone Sales Market Share by Type (2018-2029)
5.2 Global ?-Valerolactone Revenue by Type
5.2.1 Global ?-Valerolactone Historical Revenue by Type (2018-2023)
5.2.2 Global ?-Valerolactone Forecasted Revenue by Type (2024-2029)
5.2.3 Global ?-Valerolactone Revenue Market Share by Type (2018-2029)
5.3 Global ?-Valerolactone Price by Type
5.3.1 Global ?-Valerolactone Price by Type (2018-2023)
5.3.2 Global ?-Valerolactone Price Forecast by Type (2024-2029)
6 MARKET SIZE BY APPLICATION
6.1 Global ?-Valerolactone Sales by Application
6.1.1 Global ?-Valerolactone Historical Sales by Application (2018-2023)
6.1.2 Global ?-Valerolactone Forecasted Sales by Application (2024-2029)
6.1.3 Global ?-Valerolactone Sales Market Share by Application (2018-2029)
6.2 Global ?-Valerolactone Revenue by Application
6.2.1 Global ?-Valerolactone Historical Revenue by Application (2018-2023)
6.2.2 Global ?-Valerolactone Forecasted Revenue by Application (2024-2029)
6.2.3 Global ?-Valerolactone Revenue Market Share by Application (2018-2029)
6.3 Global ?-Valerolactone Price by Application
6.3.1 Global ?-Valerolactone Price by Application (2018-2023)
6.3.2 Global ?-Valerolactone Price Forecast by Application (2024-2029)
7 US & CANADA
7.1 US & Canada ?-Valerolactone Market Size by Type
7.1.1 US & Canada ?-Valerolactone Sales by Type (2018-2029)
7.1.2 US & Canada ?-Valerolactone Revenue by Type (2018-2029)
7.2 US & Canada ?-Valerolactone Market Size by Application
7.2.1 US & Canada ?-Valerolactone Sales by Application (2018-2029)
7.2.2 US & Canada ?-Valerolactone Revenue by Application (2018-2029)
7.3 US & Canada ?-Valerolactone Sales by Country
7.3.1 US & Canada ?-Valerolactone Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 US & Canada ?-Valerolactone Sales by Country (2018-2029)
7.3.3 US & Canada ?-Valerolactone Revenue by Country (2018-2029)
7.3.4 United States
7.3.5 Canada
8 EUROPE
8.1 Europe ?-Valerolactone Market Size by Type
8.1.1 Europe ?-Valerolactone Sales by Type (2018-2029)
8.1.2 Europe ?-Valerolactone Revenue by Type (2018-2029)
8.2 Europe ?-Valerolactone Market Size by Application
8.2.1 Europe ?-Valerolactone Sales by Application (2018-2029)
8.2.2 Europe ?-Valerolactone Revenue by Application (2018-2029)
8.3 Europe ?-Valerolactone Sales by Country
8.3.1 Europe ?-Valerolactone Revenue by Country: 2018 VS 2022 VS 2029
8.3.2 Europe ?-Valerolactone Sales by Country (2018-2029)
8.3.3 Europe ?-Valerolactone Revenue by Country (2018-2029)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 CHINA
9.1 China ?-Valerolactone Market Size by Type
9.1.1 China ?-Valerolactone Sales by Type (2018-2029)
9.1.2 China ?-Valerolactone Revenue by Type (2018-2029)
9.2 China ?-Valerolactone Market Size by Application
9.2.1 China ?-Valerolactone Sales by Application (2018-2029)
9.2.2 China ?-Valerolactone Revenue by Application (2018-2029)
10 ASIA (EXCLUDING CHINA)
10.1 Asia ?-Valerolactone Market Size by Type
10.1.1 Asia ?-Valerolactone Sales by Type (2018-2029)
10.1.2 Asia ?-Valerolactone Revenue by Type (2018-2029)
10.2 Asia ?-Valerolactone Market Size by Application
10.2.1 Asia ?-Valerolactone Sales by Application (2018-2029)
10.2.2 Asia ?-Valerolactone Revenue by Application (2018-2029)
10.3 Asia ?-Valerolactone Sales by Region
10.3.1 Asia ?-Valerolactone Revenue by Region: 2018 VS 2022 VS 2029
10.3.2 Asia ?-Valerolactone Revenue by Region (2018-2029)
10.3.3 Asia ?-Valerolactone Sales by Region (2018-2029)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 MIDDLE EAST, AFRICA AND LATIN AMERICA
11.1 Middle East, Africa and Latin America ?-Valerolactone Market Size by Type
11.1.1 Middle East, Africa and Latin America ?-Valerolactone Sales by Type (2018-2029)
11.1.2 Middle East, Africa and Latin America ?-Valerolactone Revenue by Type (2018-2029)
11.2 Middle East, Africa and Latin America ?-Valerolactone Market Size by Application
11.2.1 Middle East, Africa and Latin America ?-Valerolactone Sales by Application (2018-2029)
11.2.2 Middle East, Africa and Latin America ?-Valerolactone Revenue by Application (2018-2029)
11.3 Middle East, Africa and Latin America ?-Valerolactone Sales by Country
11.3.1 Middle East, Africa and Latin America ?-Valerolactone Revenue by Country: 2018 VS 2022 VS 2029
11.3.2 Middle East, Africa and Latin America ?-Valerolactone Revenue by Country (2018-2029)
11.3.3 Middle East, Africa and Latin America ?-Valerolactone Sales by Country (2018-2029)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 CORPORATE PROFILES
12.1 BASF
12.1.1 BASF Company Information
12.1.2 BASF Overview
12.1.3 BASF ?-Valerolactone Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.1.4 BASF ?-Valerolactone Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 BASF Recent Developments
12.2 Ube Industries
12.2.1 Ube Industries Company Information
12.2.2 Ube Industries Overview
12.2.3 Ube Industries ?-Valerolactone Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.2.4 Ube Industries ?-Valerolactone Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Ube Industries Recent Developments
12.3 MYJ Chemical
12.3.1 MYJ Chemical Company Information
12.3.2 MYJ Chemical Overview
12.3.3 MYJ Chemical ?-Valerolactone Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.3.4 MYJ Chemical ?-Valerolactone Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 MYJ Chemical Recent Developments
12.4 Ningbo INNO Pharmchem
12.4.1 Ningbo INNO Pharmchem Company Information
12.4.2 Ningbo INNO Pharmchem Overview
12.4.3 Ningbo INNO Pharmchem ?-Valerolactone Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.4.4 Ningbo INNO Pharmchem ?-Valerolactone Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Ningbo INNO Pharmchem Recent Developments
12.5 Skylead Pharmaceuticals & Chemicals
12.5.1 Skylead Pharmaceuticals & Chemicals Company Information
12.5.2 Skylead Pharmaceuticals & Chemicals Overview
12.5.3 Skylead Pharmaceuticals & Chemicals ?-Valerolactone Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.5.4 Skylead Pharmaceuticals & Chemicals ?-Valerolactone Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Skylead Pharmaceuticals & Chemicals Recent Developments
12.6 Penta Manufacturing
12.6.1 Penta Manufacturing Company Information
12.6.2 Penta Manufacturing Overview
12.6.3 Penta Manufacturing ?-Valerolactone Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.6.4 Penta Manufacturing ?-Valerolactone Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Penta Manufacturing Recent Developments
12.7 Zhejiang Boadge Chemical
12.7.1 Zhejiang Boadge Chemical Company Information
12.7.2 Zhejiang Boadge Chemical Overview
12.7.3 Zhejiang Boadge Chemical ?-Valerolactone Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.7.4 Zhejiang Boadge Chemical ?-Valerolactone Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Zhejiang Boadge Chemical Recent Developments
13 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
13.1 ?-Valerolactone Industry Chain Analysis
13.2 ?-Valerolactone Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 ?-Valerolactone Production Mode & Process
13.4 ?-Valerolactone Sales and Marketing
13.4.1 ?-Valerolactone Sales Channels
13.4.2 ?-Valerolactone Distributors
13.5 ?-Valerolactone Customers
14 ?-VALEROLACTONE MARKET DYNAMICS
14.1 ?-Valerolactone Industry Trends
14.2 ?-Valerolactone Market Drivers
14.3 ?-Valerolactone Market Challenges
14.4 ?-Valerolactone Market Restraints
15 KEY FINDING IN THE GLOBAL ?-VALEROLACTONE STUDY
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
1.1 ?-Valerolactone Product Introduction
1.2 Market by Type
1.2.1 Global ?-Valerolactone Market Size by Type, 2018 VS 2022 VS 2029
1.2.2 Assay: 98%
1.2.3 Assay: 99%
1.3 Market by Application
1.3.1 Global ?-Valerolactone Market Size by Application, 2018 VS 2022 VS 2029
1.3.2 Coatings, Adhesives, Resin Additives
1.3.3 Pharmaceutical and Agrochemical Intermediates
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL ?-VALEROLACTONE PRODUCTION
2.1 Global ?-Valerolactone Production Capacity (2018-2029)
2.2 Global ?-Valerolactone Production by Region: 2018 VS 2022 VS 2029
2.3 Global ?-Valerolactone Production by Region
2.3.1 Global ?-Valerolactone Historic Production by Region (2018-2023)
2.3.2 Global ?-Valerolactone Forecasted Production by Region (2024-2029)
2.3.3 Global ?-Valerolactone Production Market Share by Region (2018-2029)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 EXECUTIVE SUMMARY
3.1 Global ?-Valerolactone Revenue Estimates and Forecasts 2018-2029
3.2 Global ?-Valerolactone Revenue by Region
3.2.1 Global ?-Valerolactone Revenue by Region: 2018 VS 2022 VS 2029
3.2.2 Global ?-Valerolactone Revenue by Region (2018-2023)
3.2.3 Global ?-Valerolactone Revenue by Region (2024-2029)
3.2.4 Global ?-Valerolactone Revenue Market Share by Region (2018-2029)
3.3 Global ?-Valerolactone Sales Estimates and Forecasts 2018-2029
3.4 Global ?-Valerolactone Sales by Region
3.4.1 Global ?-Valerolactone Sales by Region: 2018 VS 2022 VS 2029
3.4.2 Global ?-Valerolactone Sales by Region (2018-2023)
3.4.3 Global ?-Valerolactone Sales by Region (2024-2029)
3.4.4 Global ?-Valerolactone Sales Market Share by Region (2018-2029)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 COMPETITION BY MANUFACTURES
4.1 Global ?-Valerolactone Sales by Manufacturers
4.1.1 Global ?-Valerolactone Sales by Manufacturers (2018-2023)
4.1.2 Global ?-Valerolactone Sales Market Share by Manufacturers (2018-2023)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of ?-Valerolactone in 2022
4.2 Global ?-Valerolactone Revenue by Manufacturers
4.2.1 Global ?-Valerolactone Revenue by Manufacturers (2018-2023)
4.2.2 Global ?-Valerolactone Revenue Market Share by Manufacturers (2018-2023)
4.2.3 Global Top 10 and Top 5 Companies by ?-Valerolactone Revenue in 2022
4.3 Global ?-Valerolactone Sales Price by Manufacturers
4.4 Global Key Players of ?-Valerolactone, Industry Ranking, 2021 VS 2022 VS 2023
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global ?-Valerolactone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of ?-Valerolactone, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of ?-Valerolactone, Product Offered and Application
4.8 Global Key Manufacturers of ?-Valerolactone, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 MARKET SIZE BY TYPE
5.1 Global ?-Valerolactone Sales by Type
5.1.1 Global ?-Valerolactone Historical Sales by Type (2018-2023)
5.1.2 Global ?-Valerolactone Forecasted Sales by Type (2024-2029)
5.1.3 Global ?-Valerolactone Sales Market Share by Type (2018-2029)
5.2 Global ?-Valerolactone Revenue by Type
5.2.1 Global ?-Valerolactone Historical Revenue by Type (2018-2023)
5.2.2 Global ?-Valerolactone Forecasted Revenue by Type (2024-2029)
5.2.3 Global ?-Valerolactone Revenue Market Share by Type (2018-2029)
5.3 Global ?-Valerolactone Price by Type
5.3.1 Global ?-Valerolactone Price by Type (2018-2023)
5.3.2 Global ?-Valerolactone Price Forecast by Type (2024-2029)
6 MARKET SIZE BY APPLICATION
6.1 Global ?-Valerolactone Sales by Application
6.1.1 Global ?-Valerolactone Historical Sales by Application (2018-2023)
6.1.2 Global ?-Valerolactone Forecasted Sales by Application (2024-2029)
6.1.3 Global ?-Valerolactone Sales Market Share by Application (2018-2029)
6.2 Global ?-Valerolactone Revenue by Application
6.2.1 Global ?-Valerolactone Historical Revenue by Application (2018-2023)
6.2.2 Global ?-Valerolactone Forecasted Revenue by Application (2024-2029)
6.2.3 Global ?-Valerolactone Revenue Market Share by Application (2018-2029)
6.3 Global ?-Valerolactone Price by Application
6.3.1 Global ?-Valerolactone Price by Application (2018-2023)
6.3.2 Global ?-Valerolactone Price Forecast by Application (2024-2029)
7 US & CANADA
7.1 US & Canada ?-Valerolactone Market Size by Type
7.1.1 US & Canada ?-Valerolactone Sales by Type (2018-2029)
7.1.2 US & Canada ?-Valerolactone Revenue by Type (2018-2029)
7.2 US & Canada ?-Valerolactone Market Size by Application
7.2.1 US & Canada ?-Valerolactone Sales by Application (2018-2029)
7.2.2 US & Canada ?-Valerolactone Revenue by Application (2018-2029)
7.3 US & Canada ?-Valerolactone Sales by Country
7.3.1 US & Canada ?-Valerolactone Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 US & Canada ?-Valerolactone Sales by Country (2018-2029)
7.3.3 US & Canada ?-Valerolactone Revenue by Country (2018-2029)
7.3.4 United States
7.3.5 Canada
8 EUROPE
8.1 Europe ?-Valerolactone Market Size by Type
8.1.1 Europe ?-Valerolactone Sales by Type (2018-2029)
8.1.2 Europe ?-Valerolactone Revenue by Type (2018-2029)
8.2 Europe ?-Valerolactone Market Size by Application
8.2.1 Europe ?-Valerolactone Sales by Application (2018-2029)
8.2.2 Europe ?-Valerolactone Revenue by Application (2018-2029)
8.3 Europe ?-Valerolactone Sales by Country
8.3.1 Europe ?-Valerolactone Revenue by Country: 2018 VS 2022 VS 2029
8.3.2 Europe ?-Valerolactone Sales by Country (2018-2029)
8.3.3 Europe ?-Valerolactone Revenue by Country (2018-2029)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 CHINA
9.1 China ?-Valerolactone Market Size by Type
9.1.1 China ?-Valerolactone Sales by Type (2018-2029)
9.1.2 China ?-Valerolactone Revenue by Type (2018-2029)
9.2 China ?-Valerolactone Market Size by Application
9.2.1 China ?-Valerolactone Sales by Application (2018-2029)
9.2.2 China ?-Valerolactone Revenue by Application (2018-2029)
10 ASIA (EXCLUDING CHINA)
10.1 Asia ?-Valerolactone Market Size by Type
10.1.1 Asia ?-Valerolactone Sales by Type (2018-2029)
10.1.2 Asia ?-Valerolactone Revenue by Type (2018-2029)
10.2 Asia ?-Valerolactone Market Size by Application
10.2.1 Asia ?-Valerolactone Sales by Application (2018-2029)
10.2.2 Asia ?-Valerolactone Revenue by Application (2018-2029)
10.3 Asia ?-Valerolactone Sales by Region
10.3.1 Asia ?-Valerolactone Revenue by Region: 2018 VS 2022 VS 2029
10.3.2 Asia ?-Valerolactone Revenue by Region (2018-2029)
10.3.3 Asia ?-Valerolactone Sales by Region (2018-2029)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 MIDDLE EAST, AFRICA AND LATIN AMERICA
11.1 Middle East, Africa and Latin America ?-Valerolactone Market Size by Type
11.1.1 Middle East, Africa and Latin America ?-Valerolactone Sales by Type (2018-2029)
11.1.2 Middle East, Africa and Latin America ?-Valerolactone Revenue by Type (2018-2029)
11.2 Middle East, Africa and Latin America ?-Valerolactone Market Size by Application
11.2.1 Middle East, Africa and Latin America ?-Valerolactone Sales by Application (2018-2029)
11.2.2 Middle East, Africa and Latin America ?-Valerolactone Revenue by Application (2018-2029)
11.3 Middle East, Africa and Latin America ?-Valerolactone Sales by Country
11.3.1 Middle East, Africa and Latin America ?-Valerolactone Revenue by Country: 2018 VS 2022 VS 2029
11.3.2 Middle East, Africa and Latin America ?-Valerolactone Revenue by Country (2018-2029)
11.3.3 Middle East, Africa and Latin America ?-Valerolactone Sales by Country (2018-2029)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 CORPORATE PROFILES
12.1 BASF
12.1.1 BASF Company Information
12.1.2 BASF Overview
12.1.3 BASF ?-Valerolactone Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.1.4 BASF ?-Valerolactone Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 BASF Recent Developments
12.2 Ube Industries
12.2.1 Ube Industries Company Information
12.2.2 Ube Industries Overview
12.2.3 Ube Industries ?-Valerolactone Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.2.4 Ube Industries ?-Valerolactone Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Ube Industries Recent Developments
12.3 MYJ Chemical
12.3.1 MYJ Chemical Company Information
12.3.2 MYJ Chemical Overview
12.3.3 MYJ Chemical ?-Valerolactone Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.3.4 MYJ Chemical ?-Valerolactone Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 MYJ Chemical Recent Developments
12.4 Ningbo INNO Pharmchem
12.4.1 Ningbo INNO Pharmchem Company Information
12.4.2 Ningbo INNO Pharmchem Overview
12.4.3 Ningbo INNO Pharmchem ?-Valerolactone Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.4.4 Ningbo INNO Pharmchem ?-Valerolactone Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Ningbo INNO Pharmchem Recent Developments
12.5 Skylead Pharmaceuticals & Chemicals
12.5.1 Skylead Pharmaceuticals & Chemicals Company Information
12.5.2 Skylead Pharmaceuticals & Chemicals Overview
12.5.3 Skylead Pharmaceuticals & Chemicals ?-Valerolactone Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.5.4 Skylead Pharmaceuticals & Chemicals ?-Valerolactone Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Skylead Pharmaceuticals & Chemicals Recent Developments
12.6 Penta Manufacturing
12.6.1 Penta Manufacturing Company Information
12.6.2 Penta Manufacturing Overview
12.6.3 Penta Manufacturing ?-Valerolactone Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.6.4 Penta Manufacturing ?-Valerolactone Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Penta Manufacturing Recent Developments
12.7 Zhejiang Boadge Chemical
12.7.1 Zhejiang Boadge Chemical Company Information
12.7.2 Zhejiang Boadge Chemical Overview
12.7.3 Zhejiang Boadge Chemical ?-Valerolactone Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.7.4 Zhejiang Boadge Chemical ?-Valerolactone Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Zhejiang Boadge Chemical Recent Developments
13 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
13.1 ?-Valerolactone Industry Chain Analysis
13.2 ?-Valerolactone Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 ?-Valerolactone Production Mode & Process
13.4 ?-Valerolactone Sales and Marketing
13.4.1 ?-Valerolactone Sales Channels
13.4.2 ?-Valerolactone Distributors
13.5 ?-Valerolactone Customers
14 ?-VALEROLACTONE MARKET DYNAMICS
14.1 ?-Valerolactone Industry Trends
14.2 ?-Valerolactone Market Drivers
14.3 ?-Valerolactone Market Challenges
14.4 ?-Valerolactone Market Restraints
15 KEY FINDING IN THE GLOBAL ?-VALEROLACTONE STUDY
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
LIST OF TABLES
Table 1. Global ?-Valerolactone Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Assay: 98%
Table 3. Major Manufacturers of Assay: 99%
Table 4. Global ?-Valerolactone Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global ?-Valerolactone Production by Region: 2018 VS 2022 VS 2029 (MT)
Table 6. Global ?-Valerolactone Production by Region (2018-2023) & (MT)
Table 7. Global ?-Valerolactone Production by Region (2024-2029) & (MT)
Table 8. Global ?-Valerolactone Production Market Share by Region (2018-2023)
Table 9. Global ?-Valerolactone Production Market Share by Region (2024-2029)
Table 10. Global ?-Valerolactone Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global ?-Valerolactone Revenue by Region (2018-2023) & (US$ Million)
Table 12. Global ?-Valerolactone Revenue by Region (2024-2029) & (US$ Million)
Table 13. Global ?-Valerolactone Revenue Market Share by Region (2018-2023)
Table 14. Global ?-Valerolactone Revenue Market Share by Region (2024-2029)
Table 15. Global ?-Valerolactone Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 16. Global ?-Valerolactone Sales by Region (2018-2023) & (MT)
Table 17. Global ?-Valerolactone Sales by Region (2024-2029) & (MT)
Table 18. Global ?-Valerolactone Sales Market Share by Region (2018-2023)
Table 19. Global ?-Valerolactone Sales Market Share by Region (2024-2029)
Table 20. Global ?-Valerolactone Sales by Manufacturers (2018-2023) & (MT)
Table 21. Global ?-Valerolactone Sales Share by Manufacturers (2018-2023)
Table 22. Global ?-Valerolactone Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 23. Global ?-Valerolactone Revenue Share by Manufacturers (2018-2023)
Table 24. ?-Valerolactone Price by Manufacturers 2018-2023 (US$/MT)
Table 25. Global Key Players of ?-Valerolactone, Industry Ranking, 2021 VS 2022 VS 2023
Table 26. Global ?-Valerolactone Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global ?-Valerolactone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ?-Valerolactone as of 2022)
Table 28. Global Key Manufacturers of ?-Valerolactone, Manufacturing Base Distribution and Headquarters
Table 29. Global Key Manufacturers of ?-Valerolactone, Product Offered and Application
Table 30. Global Key Manufacturers of ?-Valerolactone, Date of Enter into This Industry
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global ?-Valerolactone Sales by Type (2018-2023) & (MT)
Table 33. Global ?-Valerolactone Sales by Type (2024-2029) & (MT)
Table 34. Global ?-Valerolactone Sales Share by Type (2018-2023)
Table 35. Global ?-Valerolactone Sales Share by Type (2024-2029)
Table 36. Global ?-Valerolactone Revenue by Type (2018-2023) & (US$ Million)
Table 37. Global ?-Valerolactone Revenue by Type (2024-2029) & (US$ Million)
Table 38. Global ?-Valerolactone Revenue Share by Type (2018-2023)
Table 39. Global ?-Valerolactone Revenue Share by Type (2024-2029)
Table 40. ?-Valerolactone Price by Type (2018-2023) & (US$/MT)
Table 41. Global ?-Valerolactone Price Forecast by Type (2024-2029) & (US$/MT)
Table 42. Global ?-Valerolactone Sales by Application (2018-2023) & (MT)
Table 43. Global ?-Valerolactone Sales by Application (2024-2029) & (MT)
Table 44. Global ?-Valerolactone Sales Share by Application (2018-2023)
Table 45. Global ?-Valerolactone Sales Share by Application (2024-2029)
Table 46. Global ?-Valerolactone Revenue by Application (2018-2023) & (US$ Million)
Table 47. Global ?-Valerolactone Revenue by Application (2024-2029) & (US$ Million)
Table 48. Global ?-Valerolactone Revenue Share by Application (2018-2023)
Table 49. Global ?-Valerolactone Revenue Share by Application (2024-2029)
Table 50. ?-Valerolactone Price by Application (2018-2023) & (US$/MT)
Table 51. Global ?-Valerolactone Price Forecast by Application (2024-2029) & (US$/MT)
Table 52. US & Canada ?-Valerolactone Sales by Type (2018-2023) & (MT)
Table 53. US & Canada ?-Valerolactone Sales by Type (2024-2029) & (MT)
Table 54. US & Canada ?-Valerolactone Revenue by Type (2018-2023) & (US$ Million)
Table 55. US & Canada ?-Valerolactone Revenue by Type (2024-2029) & (US$ Million)
Table 56. US & Canada ?-Valerolactone Sales by Application (2018-2023) & (MT)
Table 57. US & Canada ?-Valerolactone Sales by Application (2024-2029) & (MT)
Table 58. US & Canada ?-Valerolactone Revenue by Application (2018-2023) & (US$ Million)
Table 59. US & Canada ?-Valerolactone Revenue by Application (2024-2029) & (US$ Million)
Table 60. US & Canada ?-Valerolactone Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 61. US & Canada ?-Valerolactone Revenue by Country (2018-2023) & (US$ Million)
Table 62. US & Canada ?-Valerolactone Revenue by Country (2024-2029) & (US$ Million)
Table 63. US & Canada ?-Valerolactone Sales by Country (2018-2023) & (MT)
Table 64. US & Canada ?-Valerolactone Sales by Country (2024-2029) & (MT)
Table 65. Europe ?-Valerolactone Sales by Type (2018-2023) & (MT)
Table 66. Europe ?-Valerolactone Sales by Type (2024-2029) & (MT)
Table 67. Europe ?-Valerolactone Revenue by Type (2018-2023) & (US$ Million)
Table 68. Europe ?-Valerolactone Revenue by Type (2024-2029) & (US$ Million)
Table 69. Europe ?-Valerolactone Sales by Application (2018-2023) & (MT)
Table 70. Europe ?-Valerolactone Sales by Application (2024-2029) & (MT)
Table 71. Europe ?-Valerolactone Revenue by Application (2018-2023) & (US$ Million)
Table 72. Europe ?-Valerolactone Revenue by Application (2024-2029) & (US$ Million)
Table 73. Europe ?-Valerolactone Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 74. Europe ?-Valerolactone Revenue by Country (2018-2023) & (US$ Million)
Table 75. Europe ?-Valerolactone Revenue by Country (2024-2029) & (US$ Million)
Table 76. Europe ?-Valerolactone Sales by Country (2018-2023) & (MT)
Table 77. Europe ?-Valerolactone Sales by Country (2024-2029) & (MT)
Table 78. China ?-Valerolactone Sales by Type (2018-2023) & (MT)
Table 79. China ?-Valerolactone Sales by Type (2024-2029) & (MT)
Table 80. China ?-Valerolactone Revenue by Type (2018-2023) & (US$ Million)
Table 81. China ?-Valerolactone Revenue by Type (2024-2029) & (US$ Million)
Table 82. China ?-Valerolactone Sales by Application (2018-2023) & (MT)
Table 83. China ?-Valerolactone Sales by Application (2024-2029) & (MT)
Table 84. China ?-Valerolactone Revenue by Application (2018-2023) & (US$ Million)
Table 85. China ?-Valerolactone Revenue by Application (2024-2029) & (US$ Million)
Table 86. Asia ?-Valerolactone Sales by Type (2018-2023) & (MT)
Table 87. Asia ?-Valerolactone Sales by Type (2024-2029) & (MT)
Table 88. Asia ?-Valerolactone Revenue by Type (2018-2023) & (US$ Million)
Table 89. Asia ?-Valerolactone Revenue by Type (2024-2029) & (US$ Million)
Table 90. Asia ?-Valerolactone Sales by Application (2018-2023) & (MT)
Table 91. Asia ?-Valerolactone Sales by Application (2024-2029) & (MT)
Table 92. Asia ?-Valerolactone Revenue by Application (2018-2023) & (US$ Million)
Table 93. Asia ?-Valerolactone Revenue by Application (2024-2029) & (US$ Million)
Table 94. Asia ?-Valerolactone Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 95. Asia ?-Valerolactone Revenue by Region (2018-2023) & (US$ Million)
Table 96. Asia ?-Valerolactone Revenue by Region (2024-2029) & (US$ Million)
Table 97. Asia ?-Valerolactone Sales by Region (2018-2023) & (MT)
Table 98. Asia ?-Valerolactone Sales by Region (2024-2029) & (MT)
Table 99. Middle East, Africa and Latin America ?-Valerolactone Sales by Type (2018-2023) & (MT)
Table 100. Middle East, Africa and Latin America ?-Valerolactone Sales by Type (2024-2029) & (MT)
Table 101. Middle East, Africa and Latin America ?-Valerolactone Revenue by Type (2018-2023) & (US$ Million)
Table 102. Middle East, Africa and Latin America ?-Valerolactone Revenue by Type (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America ?-Valerolactone Sales by Application (2018-2023) & (MT)
Table 104. Middle East, Africa and Latin America ?-Valerolactone Sales by Application (2024-2029) & (MT)
Table 105. Middle East, Africa and Latin America ?-Valerolactone Revenue by Application (2018-2023) & (US$ Million)
Table 106. Middle East, Africa and Latin America ?-Valerolactone Revenue by Application (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America ?-Valerolactone Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 108. Middle East, Africa and Latin America ?-Valerolactone Revenue by Country (2018-2023) & (US$ Million)
Table 109. Middle East, Africa and Latin America ?-Valerolactone Revenue by Country (2024-2029) & (US$ Million)
Table 110. Middle East, Africa and Latin America ?-Valerolactone Sales by Country (2018-2023) & (MT)
Table 111. Middle East, Africa and Latin America ?-Valerolactone Sales by Country (2024-2029) & (MT)
Table 112. BASF Company Information
Table 113. BASF Description and Major Businesses
Table 114. BASF ?-Valerolactone Capacity Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2018-2023)
Table 115. BASF ?-Valerolactone Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. BASF Recent Development
Table 117. Ube Industries Company Information
Table 118. Ube Industries Description and Major Businesses
Table 119. Ube Industries ?-Valerolactone Capacity Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2018-2023)
Table 120. Ube Industries ?-Valerolactone Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Ube Industries Recent Development
Table 122. MYJ Chemical Company Information
Table 123. MYJ Chemical Description and Major Businesses
Table 124. MYJ Chemical ?-Valerolactone Capacity Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2018-2023)
Table 125. MYJ Chemical ?-Valerolactone Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. MYJ Chemical Recent Development
Table 127. Ningbo INNO Pharmchem Company Information
Table 128. Ningbo INNO Pharmchem Description and Major Businesses
Table 129. Ningbo INNO Pharmchem ?-Valerolactone Capacity Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2018-2023)
Table 130. Ningbo INNO Pharmchem ?-Valerolactone Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Ningbo INNO Pharmchem Recent Development
Table 132. Skylead Pharmaceuticals & Chemicals Company Information
Table 133. Skylead Pharmaceuticals & Chemicals Description and Major Businesses
Table 134. Skylead Pharmaceuticals & Chemicals ?-Valerolactone Capacity Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2018-2023)
Table 135. Skylead Pharmaceuticals & Chemicals ?-Valerolactone Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Skylead Pharmaceuticals & Chemicals Recent Development
Table 137. Penta Manufacturing Company Information
Table 138. Penta Manufacturing Description and Major Businesses
Table 139. Penta Manufacturing ?-Valerolactone Capacity Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2018-2023)
Table 140. Penta Manufacturing ?-Valerolactone Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Penta Manufacturing Recent Development
Table 142. Zhejiang Boadge Chemical Company Information
Table 143. Zhejiang Boadge Chemical Description and Major Businesses
Table 144. Zhejiang Boadge Chemical ?-Valerolactone Capacity Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2018-2023)
Table 145. Zhejiang Boadge Chemical ?-Valerolactone Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Zhejiang Boadge Chemical Recent Development
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. ?-Valerolactone Distributors List
Table 150. ?-Valerolactone Customers List
Table 151. ?-Valerolactone Market Trends
Table 152. ?-Valerolactone Market Drivers
Table 153. ?-Valerolactone Market Challenges
Table 154. ?-Valerolactone Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
Table 1. Global ?-Valerolactone Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Assay: 98%
Table 3. Major Manufacturers of Assay: 99%
Table 4. Global ?-Valerolactone Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global ?-Valerolactone Production by Region: 2018 VS 2022 VS 2029 (MT)
Table 6. Global ?-Valerolactone Production by Region (2018-2023) & (MT)
Table 7. Global ?-Valerolactone Production by Region (2024-2029) & (MT)
Table 8. Global ?-Valerolactone Production Market Share by Region (2018-2023)
Table 9. Global ?-Valerolactone Production Market Share by Region (2024-2029)
Table 10. Global ?-Valerolactone Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global ?-Valerolactone Revenue by Region (2018-2023) & (US$ Million)
Table 12. Global ?-Valerolactone Revenue by Region (2024-2029) & (US$ Million)
Table 13. Global ?-Valerolactone Revenue Market Share by Region (2018-2023)
Table 14. Global ?-Valerolactone Revenue Market Share by Region (2024-2029)
Table 15. Global ?-Valerolactone Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 16. Global ?-Valerolactone Sales by Region (2018-2023) & (MT)
Table 17. Global ?-Valerolactone Sales by Region (2024-2029) & (MT)
Table 18. Global ?-Valerolactone Sales Market Share by Region (2018-2023)
Table 19. Global ?-Valerolactone Sales Market Share by Region (2024-2029)
Table 20. Global ?-Valerolactone Sales by Manufacturers (2018-2023) & (MT)
Table 21. Global ?-Valerolactone Sales Share by Manufacturers (2018-2023)
Table 22. Global ?-Valerolactone Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 23. Global ?-Valerolactone Revenue Share by Manufacturers (2018-2023)
Table 24. ?-Valerolactone Price by Manufacturers 2018-2023 (US$/MT)
Table 25. Global Key Players of ?-Valerolactone, Industry Ranking, 2021 VS 2022 VS 2023
Table 26. Global ?-Valerolactone Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global ?-Valerolactone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ?-Valerolactone as of 2022)
Table 28. Global Key Manufacturers of ?-Valerolactone, Manufacturing Base Distribution and Headquarters
Table 29. Global Key Manufacturers of ?-Valerolactone, Product Offered and Application
Table 30. Global Key Manufacturers of ?-Valerolactone, Date of Enter into This Industry
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global ?-Valerolactone Sales by Type (2018-2023) & (MT)
Table 33. Global ?-Valerolactone Sales by Type (2024-2029) & (MT)
Table 34. Global ?-Valerolactone Sales Share by Type (2018-2023)
Table 35. Global ?-Valerolactone Sales Share by Type (2024-2029)
Table 36. Global ?-Valerolactone Revenue by Type (2018-2023) & (US$ Million)
Table 37. Global ?-Valerolactone Revenue by Type (2024-2029) & (US$ Million)
Table 38. Global ?-Valerolactone Revenue Share by Type (2018-2023)
Table 39. Global ?-Valerolactone Revenue Share by Type (2024-2029)
Table 40. ?-Valerolactone Price by Type (2018-2023) & (US$/MT)
Table 41. Global ?-Valerolactone Price Forecast by Type (2024-2029) & (US$/MT)
Table 42. Global ?-Valerolactone Sales by Application (2018-2023) & (MT)
Table 43. Global ?-Valerolactone Sales by Application (2024-2029) & (MT)
Table 44. Global ?-Valerolactone Sales Share by Application (2018-2023)
Table 45. Global ?-Valerolactone Sales Share by Application (2024-2029)
Table 46. Global ?-Valerolactone Revenue by Application (2018-2023) & (US$ Million)
Table 47. Global ?-Valerolactone Revenue by Application (2024-2029) & (US$ Million)
Table 48. Global ?-Valerolactone Revenue Share by Application (2018-2023)
Table 49. Global ?-Valerolactone Revenue Share by Application (2024-2029)
Table 50. ?-Valerolactone Price by Application (2018-2023) & (US$/MT)
Table 51. Global ?-Valerolactone Price Forecast by Application (2024-2029) & (US$/MT)
Table 52. US & Canada ?-Valerolactone Sales by Type (2018-2023) & (MT)
Table 53. US & Canada ?-Valerolactone Sales by Type (2024-2029) & (MT)
Table 54. US & Canada ?-Valerolactone Revenue by Type (2018-2023) & (US$ Million)
Table 55. US & Canada ?-Valerolactone Revenue by Type (2024-2029) & (US$ Million)
Table 56. US & Canada ?-Valerolactone Sales by Application (2018-2023) & (MT)
Table 57. US & Canada ?-Valerolactone Sales by Application (2024-2029) & (MT)
Table 58. US & Canada ?-Valerolactone Revenue by Application (2018-2023) & (US$ Million)
Table 59. US & Canada ?-Valerolactone Revenue by Application (2024-2029) & (US$ Million)
Table 60. US & Canada ?-Valerolactone Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 61. US & Canada ?-Valerolactone Revenue by Country (2018-2023) & (US$ Million)
Table 62. US & Canada ?-Valerolactone Revenue by Country (2024-2029) & (US$ Million)
Table 63. US & Canada ?-Valerolactone Sales by Country (2018-2023) & (MT)
Table 64. US & Canada ?-Valerolactone Sales by Country (2024-2029) & (MT)
Table 65. Europe ?-Valerolactone Sales by Type (2018-2023) & (MT)
Table 66. Europe ?-Valerolactone Sales by Type (2024-2029) & (MT)
Table 67. Europe ?-Valerolactone Revenue by Type (2018-2023) & (US$ Million)
Table 68. Europe ?-Valerolactone Revenue by Type (2024-2029) & (US$ Million)
Table 69. Europe ?-Valerolactone Sales by Application (2018-2023) & (MT)
Table 70. Europe ?-Valerolactone Sales by Application (2024-2029) & (MT)
Table 71. Europe ?-Valerolactone Revenue by Application (2018-2023) & (US$ Million)
Table 72. Europe ?-Valerolactone Revenue by Application (2024-2029) & (US$ Million)
Table 73. Europe ?-Valerolactone Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 74. Europe ?-Valerolactone Revenue by Country (2018-2023) & (US$ Million)
Table 75. Europe ?-Valerolactone Revenue by Country (2024-2029) & (US$ Million)
Table 76. Europe ?-Valerolactone Sales by Country (2018-2023) & (MT)
Table 77. Europe ?-Valerolactone Sales by Country (2024-2029) & (MT)
Table 78. China ?-Valerolactone Sales by Type (2018-2023) & (MT)
Table 79. China ?-Valerolactone Sales by Type (2024-2029) & (MT)
Table 80. China ?-Valerolactone Revenue by Type (2018-2023) & (US$ Million)
Table 81. China ?-Valerolactone Revenue by Type (2024-2029) & (US$ Million)
Table 82. China ?-Valerolactone Sales by Application (2018-2023) & (MT)
Table 83. China ?-Valerolactone Sales by Application (2024-2029) & (MT)
Table 84. China ?-Valerolactone Revenue by Application (2018-2023) & (US$ Million)
Table 85. China ?-Valerolactone Revenue by Application (2024-2029) & (US$ Million)
Table 86. Asia ?-Valerolactone Sales by Type (2018-2023) & (MT)
Table 87. Asia ?-Valerolactone Sales by Type (2024-2029) & (MT)
Table 88. Asia ?-Valerolactone Revenue by Type (2018-2023) & (US$ Million)
Table 89. Asia ?-Valerolactone Revenue by Type (2024-2029) & (US$ Million)
Table 90. Asia ?-Valerolactone Sales by Application (2018-2023) & (MT)
Table 91. Asia ?-Valerolactone Sales by Application (2024-2029) & (MT)
Table 92. Asia ?-Valerolactone Revenue by Application (2018-2023) & (US$ Million)
Table 93. Asia ?-Valerolactone Revenue by Application (2024-2029) & (US$ Million)
Table 94. Asia ?-Valerolactone Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 95. Asia ?-Valerolactone Revenue by Region (2018-2023) & (US$ Million)
Table 96. Asia ?-Valerolactone Revenue by Region (2024-2029) & (US$ Million)
Table 97. Asia ?-Valerolactone Sales by Region (2018-2023) & (MT)
Table 98. Asia ?-Valerolactone Sales by Region (2024-2029) & (MT)
Table 99. Middle East, Africa and Latin America ?-Valerolactone Sales by Type (2018-2023) & (MT)
Table 100. Middle East, Africa and Latin America ?-Valerolactone Sales by Type (2024-2029) & (MT)
Table 101. Middle East, Africa and Latin America ?-Valerolactone Revenue by Type (2018-2023) & (US$ Million)
Table 102. Middle East, Africa and Latin America ?-Valerolactone Revenue by Type (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America ?-Valerolactone Sales by Application (2018-2023) & (MT)
Table 104. Middle East, Africa and Latin America ?-Valerolactone Sales by Application (2024-2029) & (MT)
Table 105. Middle East, Africa and Latin America ?-Valerolactone Revenue by Application (2018-2023) & (US$ Million)
Table 106. Middle East, Africa and Latin America ?-Valerolactone Revenue by Application (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America ?-Valerolactone Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 108. Middle East, Africa and Latin America ?-Valerolactone Revenue by Country (2018-2023) & (US$ Million)
Table 109. Middle East, Africa and Latin America ?-Valerolactone Revenue by Country (2024-2029) & (US$ Million)
Table 110. Middle East, Africa and Latin America ?-Valerolactone Sales by Country (2018-2023) & (MT)
Table 111. Middle East, Africa and Latin America ?-Valerolactone Sales by Country (2024-2029) & (MT)
Table 112. BASF Company Information
Table 113. BASF Description and Major Businesses
Table 114. BASF ?-Valerolactone Capacity Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2018-2023)
Table 115. BASF ?-Valerolactone Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. BASF Recent Development
Table 117. Ube Industries Company Information
Table 118. Ube Industries Description and Major Businesses
Table 119. Ube Industries ?-Valerolactone Capacity Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2018-2023)
Table 120. Ube Industries ?-Valerolactone Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Ube Industries Recent Development
Table 122. MYJ Chemical Company Information
Table 123. MYJ Chemical Description and Major Businesses
Table 124. MYJ Chemical ?-Valerolactone Capacity Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2018-2023)
Table 125. MYJ Chemical ?-Valerolactone Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. MYJ Chemical Recent Development
Table 127. Ningbo INNO Pharmchem Company Information
Table 128. Ningbo INNO Pharmchem Description and Major Businesses
Table 129. Ningbo INNO Pharmchem ?-Valerolactone Capacity Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2018-2023)
Table 130. Ningbo INNO Pharmchem ?-Valerolactone Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Ningbo INNO Pharmchem Recent Development
Table 132. Skylead Pharmaceuticals & Chemicals Company Information
Table 133. Skylead Pharmaceuticals & Chemicals Description and Major Businesses
Table 134. Skylead Pharmaceuticals & Chemicals ?-Valerolactone Capacity Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2018-2023)
Table 135. Skylead Pharmaceuticals & Chemicals ?-Valerolactone Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Skylead Pharmaceuticals & Chemicals Recent Development
Table 137. Penta Manufacturing Company Information
Table 138. Penta Manufacturing Description and Major Businesses
Table 139. Penta Manufacturing ?-Valerolactone Capacity Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2018-2023)
Table 140. Penta Manufacturing ?-Valerolactone Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Penta Manufacturing Recent Development
Table 142. Zhejiang Boadge Chemical Company Information
Table 143. Zhejiang Boadge Chemical Description and Major Businesses
Table 144. Zhejiang Boadge Chemical ?-Valerolactone Capacity Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2018-2023)
Table 145. Zhejiang Boadge Chemical ?-Valerolactone Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Zhejiang Boadge Chemical Recent Development
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. ?-Valerolactone Distributors List
Table 150. ?-Valerolactone Customers List
Table 151. ?-Valerolactone Market Trends
Table 152. ?-Valerolactone Market Drivers
Table 153. ?-Valerolactone Market Challenges
Table 154. ?-Valerolactone Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. ?-Valerolactone Product Picture
Figure 2. Global ?-Valerolactone Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global ?-Valerolactone Market Share by Type in 2022 & 2029
Figure 4. Assay: 98% Product Picture
Figure 5. Assay: 99% Product Picture
Figure 6. Global ?-Valerolactone Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global ?-Valerolactone Market Share by Application in 2022 & 2029
Figure 8. Coatings, Adhesives, Resin Additives
Figure 9. Pharmaceutical and Agrochemical Intermediates
Figure 10. ?-Valerolactone Report Years Considered
Figure 11. Global ?-Valerolactone Capacity, Production and Utilization (2018-2029) & (MT)
Figure 12. Global ?-Valerolactone Production Market Share by Region in Percentage: 2022 Versus 2029
Figure 13. Global ?-Valerolactone Production Market Share by Region (2018-2029)
Figure 14. ?-Valerolactone Production Growth Rate in North America (2018-2029) & (MT)
Figure 15. ?-Valerolactone Production Growth Rate in Europe (2018-2029) & (MT)
Figure 16. ?-Valerolactone Production Growth Rate in China (2018-2029) & (MT)
Figure 17. ?-Valerolactone Production Growth Rate in Japan (2018-2029) & (MT)
Figure 18. Global ?-Valerolactone Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 19. Global ?-Valerolactone Revenue 2018-2029 (US$ Million)
Figure 20. Global ?-Valerolactone Revenue (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Figure 21. Global ?-Valerolactone Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 22. Global ?-Valerolactone Revenue Market Share by Region (2018-2029)
Figure 23. Global ?-Valerolactone Sales 2018-2029 ((MT)
Figure 24. Global ?-Valerolactone Sales (CAGR) by Region: 2018 VS 2022 VS 2029 (MT)
Figure 25. Global ?-Valerolactone Sales Market Share by Region (2018-2029)
Figure 26. US & Canada ?-Valerolactone Sales YoY (2018-2029) & (MT)
Figure 27. US & Canada ?-Valerolactone Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Europe ?-Valerolactone Sales YoY (2018-2029) & (MT)
Figure 29. Europe ?-Valerolactone Revenue YoY (2018-2029) & (US$ Million)
Figure 30. China ?-Valerolactone Sales YoY (2018-2029) & (MT)
Figure 31. China ?-Valerolactone Revenue YoY (2018-2029) & (US$ Million)
Figure 32. Asia (excluding China) ?-Valerolactone Sales YoY (2018-2029) & (MT)
Figure 33. Asia (excluding China) ?-Valerolactone Revenue YoY (2018-2029) & (US$ Million)
Figure 34. Middle East, Africa and Latin America ?-Valerolactone Sales YoY (2018-2029) & (MT)
Figure 35. Middle East, Africa and Latin America ?-Valerolactone Revenue YoY (2018-2029) & (US$ Million)
Figure 36. The ?-Valerolactone Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 37. The Top 5 and 10 Largest Manufacturers of ?-Valerolactone in the World: Market Share by ?-Valerolactone Revenue in 2022
Figure 38. Global ?-Valerolactone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 39. Global ?-Valerolactone Sales Market Share by Type (2018-2029)
Figure 40. Global ?-Valerolactone Revenue Market Share by Type (2018-2029)
Figure 41. Global ?-Valerolactone Sales Market Share by Application (2018-2029)
Figure 42. Global ?-Valerolactone Revenue Market Share by Application (2018-2029)
Figure 43. US & Canada ?-Valerolactone Sales Market Share by Type (2018-2029)
Figure 44. US & Canada ?-Valerolactone Revenue Market Share by Type (2018-2029)
Figure 45. US & Canada ?-Valerolactone Sales Market Share by Application (2018-2029)
Figure 46. US & Canada ?-Valerolactone Revenue Market Share by Application (2018-2029)
Figure 47. US & Canada ?-Valerolactone Revenue Share by Country (2018-2029)
Figure 48. US & Canada ?-Valerolactone Sales Share by Country (2018-2029)
Figure 49. U.S. ?-Valerolactone Revenue (2018-2029) & (US$ Million)
Figure 50. Canada ?-Valerolactone Revenue (2018-2029) & (US$ Million)
Figure 51. Europe ?-Valerolactone Sales Market Share by Type (2018-2029)
Figure 52. Europe ?-Valerolactone Revenue Market Share by Type (2018-2029)
Figure 53. Europe ?-Valerolactone Sales Market Share by Application (2018-2029)
Figure 54. Europe ?-Valerolactone Revenue Market Share by Application (2018-2029)
Figure 55. Europe ?-Valerolactone Revenue Share by Country (2018-2029)
Figure 56. Europe ?-Valerolactone Sales Share by Country (2018-2029)
Figure 57. Germany ?-Valerolactone Revenue (2018-2029) & (US$ Million)
Figure 58. France ?-Valerolactone Revenue (2018-2029) & (US$ Million)
Figure 59. U.K. ?-Valerolactone Revenue (2018-2029) & (US$ Million)
Figure 60. Italy ?-Valerolactone Revenue (2018-2029) & (US$ Million)
Figure 61. Russia ?-Valerolactone Revenue (2018-2029) & (US$ Million)
Figure 62. China ?-Valerolactone Sales Market Share by Type (2018-2029)
Figure 63. China ?-Valerolactone Revenue Market Share by Type (2018-2029)
Figure 64. China ?-Valerolactone Sales Market Share by Application (2018-2029)
Figure 65. China ?-Valerolactone Revenue Market Share by Application (2018-2029)
Figure 66. Asia ?-Valerolactone Sales Market Share by Type (2018-2029)
Figure 67. Asia ?-Valerolactone Revenue Market Share by Type (2018-2029)
Figure 68. Asia ?-Valerolactone Sales Market Share by Application (2018-2029)
Figure 69. Asia ?-Valerolactone Revenue Market Share by Application (2018-2029)
Figure 70. Asia ?-Valerolactone Revenue Share by Region (2018-2029)
Figure 71. Asia ?-Valerolactone Sales Share by Region (2018-2029)
Figure 72. Japan ?-Valerolactone Revenue (2018-2029) & (US$ Million)
Figure 73. South Korea ?-Valerolactone Revenue (2018-2029) & (US$ Million)
Figure 74. China Taiwan ?-Valerolactone Revenue (2018-2029) & (US$ Million)
Figure 75. Southeast Asia ?-Valerolactone Revenue (2018-2029) & (US$ Million)
Figure 76. India ?-Valerolactone Revenue (2018-2029) & (US$ Million)
Figure 77. Middle East, Africa and Latin America ?-Valerolactone Sales Market Share by Type (2018-2029)
Figure 78. Middle East, Africa and Latin America ?-Valerolactone Revenue Market Share by Type (2018-2029)
Figure 79. Middle East, Africa and Latin America ?-Valerolactone Sales Market Share by Application (2018-2029)
Figure 80. Middle East, Africa and Latin America ?-Valerolactone Revenue Market Share by Application (2018-2029)
Figure 81. Middle East, Africa and Latin America ?-Valerolactone Revenue Share by Country (2018-2029)
Figure 82. Middle East, Africa and Latin America ?-Valerolactone Sales Share by Country (2018-2029)
Figure 83. Brazil ?-Valerolactone Revenue (2018-2029) & (US$ Million)
Figure 84. Mexico ?-Valerolactone Revenue (2018-2029) & (US$ Million)
Figure 85. Turkey ?-Valerolactone Revenue (2018-2029) & (US$ Million)
Figure 86. Israel ?-Valerolactone Revenue (2018-2029) & (US$ Million)
Figure 87. GCC Countries ?-Valerolactone Revenue (2018-2029) & (US$ Million)
Figure 88. ?-Valerolactone Value Chain
Figure 89. ?-Valerolactone Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
Figure 1. ?-Valerolactone Product Picture
Figure 2. Global ?-Valerolactone Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global ?-Valerolactone Market Share by Type in 2022 & 2029
Figure 4. Assay: 98% Product Picture
Figure 5. Assay: 99% Product Picture
Figure 6. Global ?-Valerolactone Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global ?-Valerolactone Market Share by Application in 2022 & 2029
Figure 8. Coatings, Adhesives, Resin Additives
Figure 9. Pharmaceutical and Agrochemical Intermediates
Figure 10. ?-Valerolactone Report Years Considered
Figure 11. Global ?-Valerolactone Capacity, Production and Utilization (2018-2029) & (MT)
Figure 12. Global ?-Valerolactone Production Market Share by Region in Percentage: 2022 Versus 2029
Figure 13. Global ?-Valerolactone Production Market Share by Region (2018-2029)
Figure 14. ?-Valerolactone Production Growth Rate in North America (2018-2029) & (MT)
Figure 15. ?-Valerolactone Production Growth Rate in Europe (2018-2029) & (MT)
Figure 16. ?-Valerolactone Production Growth Rate in China (2018-2029) & (MT)
Figure 17. ?-Valerolactone Production Growth Rate in Japan (2018-2029) & (MT)
Figure 18. Global ?-Valerolactone Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 19. Global ?-Valerolactone Revenue 2018-2029 (US$ Million)
Figure 20. Global ?-Valerolactone Revenue (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Figure 21. Global ?-Valerolactone Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 22. Global ?-Valerolactone Revenue Market Share by Region (2018-2029)
Figure 23. Global ?-Valerolactone Sales 2018-2029 ((MT)
Figure 24. Global ?-Valerolactone Sales (CAGR) by Region: 2018 VS 2022 VS 2029 (MT)
Figure 25. Global ?-Valerolactone Sales Market Share by Region (2018-2029)
Figure 26. US & Canada ?-Valerolactone Sales YoY (2018-2029) & (MT)
Figure 27. US & Canada ?-Valerolactone Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Europe ?-Valerolactone Sales YoY (2018-2029) & (MT)
Figure 29. Europe ?-Valerolactone Revenue YoY (2018-2029) & (US$ Million)
Figure 30. China ?-Valerolactone Sales YoY (2018-2029) & (MT)
Figure 31. China ?-Valerolactone Revenue YoY (2018-2029) & (US$ Million)
Figure 32. Asia (excluding China) ?-Valerolactone Sales YoY (2018-2029) & (MT)
Figure 33. Asia (excluding China) ?-Valerolactone Revenue YoY (2018-2029) & (US$ Million)
Figure 34. Middle East, Africa and Latin America ?-Valerolactone Sales YoY (2018-2029) & (MT)
Figure 35. Middle East, Africa and Latin America ?-Valerolactone Revenue YoY (2018-2029) & (US$ Million)
Figure 36. The ?-Valerolactone Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 37. The Top 5 and 10 Largest Manufacturers of ?-Valerolactone in the World: Market Share by ?-Valerolactone Revenue in 2022
Figure 38. Global ?-Valerolactone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 39. Global ?-Valerolactone Sales Market Share by Type (2018-2029)
Figure 40. Global ?-Valerolactone Revenue Market Share by Type (2018-2029)
Figure 41. Global ?-Valerolactone Sales Market Share by Application (2018-2029)
Figure 42. Global ?-Valerolactone Revenue Market Share by Application (2018-2029)
Figure 43. US & Canada ?-Valerolactone Sales Market Share by Type (2018-2029)
Figure 44. US & Canada ?-Valerolactone Revenue Market Share by Type (2018-2029)
Figure 45. US & Canada ?-Valerolactone Sales Market Share by Application (2018-2029)
Figure 46. US & Canada ?-Valerolactone Revenue Market Share by Application (2018-2029)
Figure 47. US & Canada ?-Valerolactone Revenue Share by Country (2018-2029)
Figure 48. US & Canada ?-Valerolactone Sales Share by Country (2018-2029)
Figure 49. U.S. ?-Valerolactone Revenue (2018-2029) & (US$ Million)
Figure 50. Canada ?-Valerolactone Revenue (2018-2029) & (US$ Million)
Figure 51. Europe ?-Valerolactone Sales Market Share by Type (2018-2029)
Figure 52. Europe ?-Valerolactone Revenue Market Share by Type (2018-2029)
Figure 53. Europe ?-Valerolactone Sales Market Share by Application (2018-2029)
Figure 54. Europe ?-Valerolactone Revenue Market Share by Application (2018-2029)
Figure 55. Europe ?-Valerolactone Revenue Share by Country (2018-2029)
Figure 56. Europe ?-Valerolactone Sales Share by Country (2018-2029)
Figure 57. Germany ?-Valerolactone Revenue (2018-2029) & (US$ Million)
Figure 58. France ?-Valerolactone Revenue (2018-2029) & (US$ Million)
Figure 59. U.K. ?-Valerolactone Revenue (2018-2029) & (US$ Million)
Figure 60. Italy ?-Valerolactone Revenue (2018-2029) & (US$ Million)
Figure 61. Russia ?-Valerolactone Revenue (2018-2029) & (US$ Million)
Figure 62. China ?-Valerolactone Sales Market Share by Type (2018-2029)
Figure 63. China ?-Valerolactone Revenue Market Share by Type (2018-2029)
Figure 64. China ?-Valerolactone Sales Market Share by Application (2018-2029)
Figure 65. China ?-Valerolactone Revenue Market Share by Application (2018-2029)
Figure 66. Asia ?-Valerolactone Sales Market Share by Type (2018-2029)
Figure 67. Asia ?-Valerolactone Revenue Market Share by Type (2018-2029)
Figure 68. Asia ?-Valerolactone Sales Market Share by Application (2018-2029)
Figure 69. Asia ?-Valerolactone Revenue Market Share by Application (2018-2029)
Figure 70. Asia ?-Valerolactone Revenue Share by Region (2018-2029)
Figure 71. Asia ?-Valerolactone Sales Share by Region (2018-2029)
Figure 72. Japan ?-Valerolactone Revenue (2018-2029) & (US$ Million)
Figure 73. South Korea ?-Valerolactone Revenue (2018-2029) & (US$ Million)
Figure 74. China Taiwan ?-Valerolactone Revenue (2018-2029) & (US$ Million)
Figure 75. Southeast Asia ?-Valerolactone Revenue (2018-2029) & (US$ Million)
Figure 76. India ?-Valerolactone Revenue (2018-2029) & (US$ Million)
Figure 77. Middle East, Africa and Latin America ?-Valerolactone Sales Market Share by Type (2018-2029)
Figure 78. Middle East, Africa and Latin America ?-Valerolactone Revenue Market Share by Type (2018-2029)
Figure 79. Middle East, Africa and Latin America ?-Valerolactone Sales Market Share by Application (2018-2029)
Figure 80. Middle East, Africa and Latin America ?-Valerolactone Revenue Market Share by Application (2018-2029)
Figure 81. Middle East, Africa and Latin America ?-Valerolactone Revenue Share by Country (2018-2029)
Figure 82. Middle East, Africa and Latin America ?-Valerolactone Sales Share by Country (2018-2029)
Figure 83. Brazil ?-Valerolactone Revenue (2018-2029) & (US$ Million)
Figure 84. Mexico ?-Valerolactone Revenue (2018-2029) & (US$ Million)
Figure 85. Turkey ?-Valerolactone Revenue (2018-2029) & (US$ Million)
Figure 86. Israel ?-Valerolactone Revenue (2018-2029) & (US$ Million)
Figure 87. GCC Countries ?-Valerolactone Revenue (2018-2029) & (US$ Million)
Figure 88. ?-Valerolactone Value Chain
Figure 89. ?-Valerolactone Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
